NCT06337266Completed
A Novel Online Calculator to Predict Long-term Survival and Recurrence Risk of Patients With Gastric Adenocarcinoma
A Novel Online Calculator to Predict Long-term Survival and Recurrence Risk of Patients With Gastric Adenocarcinoma After Radical Gastrectomy : A Multicenter Real-world Study
Source: ClinicalTrials.gov · Last updated 29 Mar 2024
Brief summary (registry, in English)
This study aimed to develop a novel Prognostic Oxidative Stress-Immune-Inflammatory Score (POSII Score) and introduce an innovative online calculator designed to predict long-term survival and assess the recurrence risk of gastric cancer (GC).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 3622 (actual)
- First submitted
- 19 Mar 2024
- Start date
- 1 Jan 2023
- Primary completion date
- 20 Aug 2023
- Lead sponsor
- Fujian Medical University
- NCT number
- NCT06337266
What you commit to
- Study type: Observational
- Participants enrolled: 3622
- From 1 Jan 2023 to the primary completion date, 20 Aug 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fujian Medical University Union Hospital Coordinator of this site? Confirm its status | Fuzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.